Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

NCT02307279

completednot_applicable

SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)

NCT04257123

completednot_applicable

The Effect of Gelesis100 on the Pharmacokinetics of Metformin

NCT02524821

completednot_applicable

A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects

NCT02487602

Clinical Trials (4)

Showing 4 of 4 trials

NCT02307279Not Applicable

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

Completed

NCT04257123Not Applicable

SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)

Completed

NCT02524821Not Applicable

The Effect of Gelesis100 on the Pharmacokinetics of Metformin

Completed

NCT02487602Not Applicable

A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4